Supporting this hypothesis, the Th2 regulators, Interleukin-4 (IL4) and 13 (IL13), as well as IL10, have been demonstrated to play important roles during primary tumor progression in mouse models of cancer [19,20,21]. This evidence concerns the gene IL10 and neoplasm.